OBJECTIVE: To assess the association of total isoflavone intake with ovulatory function, including sporadic anovulation in healthy premenopausal women. DESIGN: Prospective cohort study. SETTING: University. PATIENT(S): Participants included 259 healthy regularly menstruating women aged 18-44 years. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Serum concentrations of E2, free E2, P, LH, FSH, and SHBG and sporadic anovulation in healthy premenopausal women. RESULT(S): Isoflavone intake was not associated with E2, free E2, P, LH, and FSH concentrations. Consumption in the highest quartile (Q4: 1.6-78.8 mg/d) was significantly associated with greater SHBG concentrations (β = 0.09; 95% confidence interval [CI] 0.02-0.16), compared with the first quartile (Q1: 0.0-0.3 mg/d). CONCLUSION(S): Isoflavone intake was not associated with sporadic anovulation (Q4 vs. Q1: odds ratio 0.87, 95% CI 0.32-1.66). Dietary isoflavone intake among young premenopausal women was not related to sex hormone concentrations or anovulation, but was associated with minimally increased SHBG concentrations. These results suggest potential endocrine effects with no subsequent effects on ovulation, easing concerns regarding their impacts on fertility. Published by Elsevier Inc.
OBJECTIVE: To assess the association of total isoflavone intake with ovulatory function, including sporadic anovulation in healthy premenopausal women. DESIGN: Prospective cohort study. SETTING: University. PATIENT(S): Participants included 259 healthy regularly menstruating women aged 18-44 years. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Serum concentrations of E2, free E2, P, LH, FSH, and SHBG and sporadic anovulation in healthy premenopausal women. RESULT(S): Isoflavone intake was not associated with E2, free E2, P, LH, and FSH concentrations. Consumption in the highest quartile (Q4: 1.6-78.8 mg/d) was significantly associated with greater SHBG concentrations (β = 0.09; 95% confidence interval [CI] 0.02-0.16), compared with the first quartile (Q1: 0.0-0.3 mg/d). CONCLUSION(S): Isoflavone intake was not associated with sporadic anovulation (Q4 vs. Q1: odds ratio 0.87, 95% CI 0.32-1.66). Dietary isoflavone intake among young premenopausal women was not related to sex hormone concentrations or anovulation, but was associated with minimally increased SHBG concentrations. These results suggest potential endocrine effects with no subsequent effects on ovulation, easing concerns regarding their impacts on fertility. Published by Elsevier Inc.
Entities:
Keywords:
Isoflavone; anovulation; nutrition; sex hormones
Authors: N L Petrakis; S Barnes; E B King; J Lowenstein; J Wiencke; M M Lee; R Miike; M Kirk; L Coward Journal: Cancer Epidemiol Biomarkers Prev Date: 1996-10 Impact factor: 4.254
Authors: G G Kuiper; J G Lemmen; B Carlsson; J C Corton; S H Safe; P T van der Saag; B van der Burg; J A Gustafsson Journal: Endocrinology Date: 1998-10 Impact factor: 4.736
Authors: Amelia K Wesselink; Elizabeth E Hatch; Ellen M Mikkelsen; Ellen Trolle; Sydney K Willis; Susan E McCann; Liisa Valsta; Annamari Lundqvist; Katherine L Tucker; Kenneth J Rothman; Lauren A Wise Journal: J Nutr Date: 2020-05-01 Impact factor: 4.798
Authors: Keewan Kim; Samrawit F Yisahak; Carrie J Nobles; Victoria C Andriessen; Elizabeth A DeVilbiss; Lindsey A Sjaarda; Ahoud Alohali; Neil J Perkins; Sunni L Mumford Journal: J Clin Endocrinol Metab Date: 2021-06-16 Impact factor: 5.958
Authors: Lindsay D Levine; Keewan Kim; Alexandra Purdue-Smithe; Rajeshwari Sundaram; Enrique F Schisterman; Matthew Connell; Elizabeth A Devilbiss; Zeina Alkhalaf; Jeannie G Radoc; Germaine M Buck Louis; Sunni L Mumford Journal: J Endocr Soc Date: 2019-12-05